The next decade of immune checkpoint therapy
P Sharma, BA Siddiqui, S Anandhan, SS Yadav… - Cancer discovery, 2021 - AACR
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
The Next Decade of Immune Checkpoint Therapy
P Sharma, BA Siddiqui, S Anandhan, SS Yadav… - Cancer …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title/>< jats: p> Immune checkpoint
therapy (ICT) can provide durable clinical responses and improve overall survival. However …
therapy (ICT) can provide durable clinical responses and improve overall survival. However …
The Next Decade of Immune Checkpoint Therapy.
P Sharma, BA Siddiqui, S Anandhan, SS Yadav… - Cancer …, 2021 - europepmc.org
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
The next decade of immune checkpoint therapy
P Sharma, BA Siddiqui, S Anandhan… - Cancer …, 2021 - mdanderson.elsevierpure.com
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
The Next Decade of Immune Checkpoint Therapy
P Sharma, BA Siddiqui, S Anandhan… - Cancer …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint therapy (ICT) can provide durable clinical responses and improve
overall survival. However, only subsets of patients with specific tumor types respond to ICT …
overall survival. However, only subsets of patients with specific tumor types respond to ICT …